Institute of Cancer Research: Major Trial Shows Breast Cancer Drug Can Hit Prostate Cancer Achilles Heel
April 29, 2020
April 29, 2020
LONDON, England, April 29 -- The Institute of Cancer Research issued the following news release on April 28:
A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.
Olaparib, a pill lacking the side effects of chemotherapy, can target an Achilles heel in prostate cancers with a weakness in their ability to . . .
A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.
Olaparib, a pill lacking the side effects of chemotherapy, can target an Achilles heel in prostate cancers with a weakness in their ability to . . .